Evexia Lifecare Q1 FY27 Results (BSE: 524444)

· Analysis by Alpha Inflection

Signal: Margin pressure

The read

The key inflection is renewed revenue growth of 39.8% YoY after Q2FY26's 3.7% decline and Q3FY26's 16.3% growth, but the trajectory remains low quality: gross margin compressed 567bps YoY to 2.6%, EBITDA margin fell 268bps to 2.2%, and PAT declined 33.9% to ₹41.98 lakh; the 26.3%-of-PBT contribution from other income further weakens earnings quality.

Evexia Lifecare Q1 FY27 key financials
MetricValueYoYQoQ
Revenue₹30.89 Cr+39.8%-16.0%
EBIT₹0.57 CrN/A
Net profit₹0.42 Cr-33.9%
EPS₹0-33.3%
EBIT margin2.2%

P&L walk

Consolidated revenue increased to ₹3,089.21 lakh, +39.8% YoY, but gross margin compressed to 2.6% from 8.2% and EBITDA margin fell to 2.2% from 4.9%; PAT declined to ₹41.98 lakh from ₹63.48 lakh despite ₹15.14 lakh of other income.

Segments

Consolidated revenue of ₹3,089.21 lakh exceeded standalone revenue of ₹2,965.91 lakh by ₹123.30 lakh, while consolidated PAT of ₹41.98 lakh was only ₹0.49 lakh above standalone PAT, indicating limited profit contribution from subsidiaries; the new EV division contributed just ₹2.72 lakh of revenue.

Key positives

Key concerns

Earnings quality: includes non-operating other income

View original filing

Research and educational content only. Not investment advice.